Jodie McVernon

6.0k total citations
177 papers, 3.9k citations indexed

About

Jodie McVernon is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Jodie McVernon has authored 177 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Epidemiology, 71 papers in Infectious Diseases and 68 papers in Modeling and Simulation. Recurrent topics in Jodie McVernon's work include Influenza Virus Research Studies (83 papers), COVID-19 epidemiological studies (68 papers) and Bacterial Infections and Vaccines (34 papers). Jodie McVernon is often cited by papers focused on Influenza Virus Research Studies (83 papers), COVID-19 epidemiological studies (68 papers) and Bacterial Infections and Vaccines (34 papers). Jodie McVernon collaborates with scholars based in Australia, United Kingdom and United States. Jodie McVernon's co-authors include James M. McCaw, Mary Ramsay, Mary Slack, Nick Andrews, John D. Mathews, Nicholas Geard, Patricia T. Campbell, Terry Nolan, Peter Richmond and Caroline Trotter and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

Jodie McVernon

171 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jodie McVernon Australia	35	2.6k	1.0k	977	921	440	177	3.9k
Susan S. Chiu Hong Kong	34	3.1k 1.2×	752 0.7×	2.0k 2.1×	338 0.4×	322 0.7×	94	4.9k
Nigel Gay United Kingdom	36	3.1k 1.2×	841 0.8×	786 0.8×	675 0.7×	230 0.5×	62	4.1k
Stefania Salmaso Italy	26	3.2k 1.2×	1.5k 1.5×	1.2k 1.2×	1.7k 1.9×	175 0.4×	67	5.3k
Ismael R. Ortega‐Sanchez United States	27	4.3k 1.7×	515 0.5×	1.1k 1.2×	773 0.8×	457 1.0×	62	5.5k
D Lévy-Brühl France	40	3.7k 1.4×	1.2k 1.1×	2.0k 2.0×	1.0k 1.1×	384 0.9×	240	6.2k
Cheryl Cohen South Africa	43	4.4k 1.7×	832 0.8×	3.1k 3.2×	581 0.6×	315 0.7×	253	7.7k
Nicholas C. Grassly United Kingdom	42	1.3k 0.5×	857 0.8×	2.8k 2.9×	419 0.5×	261 0.6×	124	5.6k
Shanta M. Zimmer United States	25	1.2k 0.5×	446 0.4×	1.1k 1.2×	272 0.3×	409 0.9×	56	2.8k
Kari Auranen Finland	28	2.4k 0.9×	1.5k 1.4×	720 0.7×	702 0.8×	68 0.2×	99	3.8k
Lara J. Wolfson United States	26	2.9k 1.1×	271 0.3×	595 0.6×	923 1.0×	337 0.8×	63	4.5k

Countries citing papers authored by Jodie McVernon

Since Specialization

Citations

This map shows the geographic impact of Jodie McVernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodie McVernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodie McVernon more than expected).

Fields of papers citing papers by Jodie McVernon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodie McVernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodie McVernon. The network helps show where Jodie McVernon may publish in the future.

Co-authorship network of co-authors of Jodie McVernon

This figure shows the co-authorship network connecting the top 25 collaborators of Jodie McVernon. A scholar is included among the top collaborators of Jodie McVernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodie McVernon. Jodie McVernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bansal, Amit, Mai-Chi Trieu, Emily M. Eriksson, et al.. (2025). SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis. Scientific Reports. 15(1). 4705–4705.

Le, Thao P., Patricia T. Campbell, Alexandra B. Hogan, et al.. (2024). Modelling the impact of hybrid immunity on future COVID-19 epidemic waves. BMC Infectious Diseases. 24(1). 407–407. 1 indexed citations

Shearer, Freya M., James M. McCaw, Gerard E. Ryan, et al.. (2024). Estimating the impact of test–trace–isolate–quarantine systems on SARS-CoV-2 transmission in Australia. Epidemics. 47. 100764–100764. 3 indexed citations

Carville, Kylie, Niamh Meagher, Yara‐Natalie Abo, et al.. (2024). Burden of antimicrobial prescribing in primary care attributable to sore throat: a retrospective cohort study of patient record data. BMC Primary Care. 25(1). 117–117.

Abeysuriya, Romesh, Rachel Sacks‐Davis, Katherine Heath, et al.. (2023). Keeping kids in school: modelling school-based testing and quarantine strategies during the COVID-19 pandemic in Australia. Frontiers in Public Health. 11. 1150810–1150810. 6 indexed citations

Zachreson, Cameron, Freya M. Shearer, David J. Price, et al.. (2022). COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2. Science Advances. 8(14). eabm3624–eabm3624. 16 indexed citations

Bowen, Asha C, et al.. (2022). Body distribution of impetigo and association with host and pathogen factors. PeerJ. 10. e14154–e14154.

Dorjee, Sithar, et al.. (2021). Antibiotic Prescription in Veterinary Consultations in Bhutan: A Retrospective Cross-Sectional Study. Frontiers in Veterinary Science. 8. 641488–641488. 2 indexed citations

Shearer, Freya M., Robert Moss, Jodie McVernon, Joshua V. Ross, & James M. McCaw. (2020). Infectious disease pandemic planning and response: Incorporating decision analysis. PLoS Medicine. 17(1). e1003018–e1003018. 55 indexed citations

10.

Chisholm, Rebecca H., Jake A. Lacey, Malcolm McDonald, et al.. (2020). Epidemiological consequences of enduring strain-specific immunity requiring repeated episodes of infection. PLoS Computational Biology. 16(6). e1007182–e1007182. 5 indexed citations

11.

Campbell, Patricia T., David J. Price, Yue Wu, et al.. (2020). Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data. PLoS Computational Biology. 16(10). e1007838–e1007838. 7 indexed citations

12.

Geard, Nicholas, James Fielding, Sabine Braat, et al.. (2019). Optimal timing of influenza vaccine during pregnancy: A systematic review and meta‐analysis. Influenza and Other Respiratory Viruses. 13(5). 438–452. 50 indexed citations

13.

McCaw, James M., Kristian M. Forbes, Garry Robins, et al.. (2012). Influence of Contact Definitions in Assessment of the Relative Importance of Social Settings in Disease Transmission Risk. PLoS ONE. 7(2). e30893–e30893. 13 indexed citations

14.

Dafilis, Mathew P., Robert Moss, Jodie McVernon, & James M. McCaw. (2012). Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response. Epidemics. 4(4). 219–226. 3 indexed citations

15.

McCaw, James M., Robert Moss, & Jodie McVernon. (2011). A decision support tool for evaluating the impact of a diagnostic-capacity and antiviral-delivery constrained intervention strategy on an influenza pandemic. Influenza and Other Respiratory Viruses. 5. 4 indexed citations

16.

McCaw, James M., Kristian M. Forbes, Philippa Pattison, et al.. (2010). Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks. BMC Infectious Diseases. 10(1). 166–166. 43 indexed citations

17.

Nolan, Terry, Peter Richmond, Helen Marshall, et al.. (2010). Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine. The Pediatric Infectious Disease Journal. 30(3). 190–196. 21 indexed citations

18.

McCaw, James M., James Wood, Emma S. McBryde, et al.. (2009). Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile. The Medical Journal of Australia. 191(3). 136–137. 5 indexed citations

19.

McCaw, James M., et al.. (2008). Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs. PLoS ONE. 3(6). e2362–e2362. 45 indexed citations

20.

Trotter, Caroline, et al.. (2003). Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. The Lancet. 361(9368). 1523–1524. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact